CardioNet, Inc. (BEAT)

[StockLogistics]

Patent doesn’t fix this imo:

“4:21p ET 8/11/2022 - Benzinga
BioTelemetry Q2 EPS $(0.43) Misses $(0.27) Estimate

BioTelemetry (NASDAQ:BEAT) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.27) by 59.26 percent.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

[starkd748]

I'll wait for the gap to fill for a scalp....Play the technicals not a stoooopid pr....No contracts listed no revenue....Patent great nothing else....In this economic climate I never buy in an overbought chart I'm only buying into gap filled charts with beaten stochastic rsi for a flip...Im shorting everything else ...Global recession on its way...Wait till winter going get super uooogly in the EU...Full of shiiid hole countries with no energy independence....

[lowercaseBACON]

Awful market. No fun

[RAlbert]

Overall market is down today. BEAT is still in better shape given the low share structure.

[starkd748]

Of course it is look at the chart...You guys need to use technical analysis before buying lol...

[goingUPagain]

Gotta be heavily shorted?!

[starkd748]

https://www.tradingview.com/x/gN54SHkz/

Dat gap will fill..

[starkd748]

Technical analysis...Look at the the stochastic rsi..Look at the gap on the chart.

[StockLogistics]

How can this stock have traded 100 million shares yesterday with a float of less than 4 million. 4 million of those shares didn’t hold for one day?

[goingUPagain]

Looks like they are trying to keep beat down..

[starkd748]

Gap fill lol

[starkd748]

Big Gap will get filled..Will it go after that in this market ummm....Rule #1 never trade plays with a gap came back after the gap fill and the stochastic is oversold

[MACH1351CJ]

I'm not optimistic. I think this will be maipulated down for a long time, just like it was yesterday. I hope I'm wrong, I usualy am:)

[MT101]

Agreed I think $12 here just in the short term (next week) with this patent can easily be worth $50-100 a share

[Triple nickle]

Careful may go to 1.50 ish

[subslover]

Haha, HUGE just Gargantuan! I sold 75% of my holdings and now have plenty of cabbage for other beauties! Loving all this NASDAQ action

[crudeoil24]

BEAT > 3.5M trading float. Running strong into closing bell.

[crudeoil24]

Investors are forward looking! Tutes, endowment funds, pension funds, and mutual funds accumulating!

[crudeoil24]

BEAT IS A GREAT $$$$$ OPPORTUNITY.

[lowercaseBACON]

I’m difficult to impress but I really like this news today. Heart attacks are a race against time and BEAT now has ghe upper hand. This is exciting to say the least! Just my opinion.

[lowercaseBACON]

$12 sounds way too low. Try $50. This is a collosal development!

[MT101]

$12+ PT here from multiple sources

[Pedro2004]

WTF -- I was watching this starting to run (80%), then there was a massive dump of shares and killed everything.

[MT101]

$5+ easily today. Massive volume! This shows up on the scanner for top 5 volume of all stocks today!

[TheFinalCD]

no but thanks for the heads up ....

as you know I am alot of places but cant be at them all

LOL

[subslover]

Are you still in this? https://ih.advfn.com/stock-market/NASDAQ/heartbeam-BEAT/stock-news/89071992/heartbeam-granted-patent-for-12-lead-electrocardio

[TheFinalCD]

https://ih.advfn.com/stock-market/NASDAQ/heartbeam-BEAT/stock-news/87941695/heartbeam-to-host-first-quarter-2022-results-confe

[mining101]

Super bullish

[mining101]

News

[mining101]

Woooooo

[TrendTrade2016]

BEAT gappa today...3.90 out of the gate!!

[TrendTrade2016]

BEAT low float showing its true colors!

[TrendTrade2016]

BEAT 4.38 up a head

[Jess070283]

Fill that gap!$$$$

[TrendTrade2016]

drums are beating now!!

[TrendTrade2016]

BEAT low floater showing signs

[TheFinalCD]

michael jackson just "_ _ _ _ " it

[TrendTrade2016]

BEAT the drums...we are starting to dance!!!!

[TrendTrade2016]

the drums are going to BEAT@@@@@@@@

[TrendTrade2016]

BEAT get ready to rumble.....in the jungle

[bcapps66]

The ticker for this stock is very appropriate....BEAT! As in BEAT the F**K UP.

[bcapps66]

What is wrong with this turd??

[BONGO68]

https://www.tipranks.com/stocks/beat/forecast

[BONGO68]

OVER 2,000,000 SOAKED UP OUT OF 7,000,000 OUTSTANDING SHARES THIS WEEK BY INSIDERS... SHOULD BE A HUGE BOUNCE ANY DAY... MAYBE BACK TO $73.00

[conix]

Hard to BEAT-- Black Friday deal

[conix]

Hard to BEAT

[Actualfactual]

Same here. Grabbed some 4.40’s to start

[honest dave]

BEAT trading $1.60 below IPO crazy. I'll take the bait.

[Bcl40004$]

Sorry to say BTCY is going to take some of BEat market share. REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will be actively pursuing the Holter market in addition to the MCT market with its Bioflux product offering, expanding its revenue growth opportunities. Bioflux is a 3 in 1 monitoring solution, offering mobile cardiac telemetry (MCT), event, and Holter monitoring. Until now, the Company has primarily focused on the MCT market, recognizing that the future of patient monitoring lies in its real-time and remote capacities. This is because healthcare delivery is undergoing a seismic shift as connectivity becomes cheaper and ubiquitous, and as medical procedures and the point of care shifts to outpatient settings.

"We believe the future is in real-time, connected healthcare," said Mr. Waqaas Al-Siddiq, Biotricity Founder and CEO. "While MCT monitoring has always been the primary focus of our Bioflux solution, we are starting to realize that there is a significant demand for Holter services because many physicians value the traditional approach offered by short-term monitoring. As a result, we are now pursuing the entire cardiac arrhythmia market to expand our revenue growth opportunities."

Biotricity's unique Holter capability leverages the Company's mobile cardiac telemetry (MCT) technology and is connectivity-enabled, which means that physicians are able to ensure in real-time that patient data is being collected accurately during the prescribed study period. Traditional Holter monitors typically have no connectivity, which effectively precludes physicians from ensuring that patient data is being collected during a study period until after the study has been completed. With its Holter capability, Biotricity can access clear ECG traces on a Holter report at any time, ensuring the collection of high-fidelity patient data. Physicians whose patients are using Bioflux are able to initiate a Holter study and obtain a high-quality, full-featured Holter report through an automated portal workflow quickly and conveniently

[JohnCM]

BEAT monster stock